Glen J. Weiss

12.7k total citations · 1 hit paper
209 papers, 7.9k citations indexed

About

Glen J. Weiss is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Glen J. Weiss has authored 209 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Oncology, 81 papers in Molecular Biology and 79 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Glen J. Weiss's work include Lung Cancer Treatments and Mutations (57 papers), Lung Cancer Research Studies (34 papers) and Cancer Genomics and Diagnostics (31 papers). Glen J. Weiss is often cited by papers focused on Lung Cancer Treatments and Mutations (57 papers), Lung Cancer Research Studies (34 papers) and Cancer Genomics and Diagnostics (31 papers). Glen J. Weiss collaborates with scholars based in United States, Spain and Germany. Glen J. Weiss's co-authors include Daniel D. Von Hoff, Raoul Tibes, Kristi Allen, Patricia LoRusso, Mitesh J. Borad, Avner Shemer, Charles M. Rudin, Alfredo Addeo, Ramesh K. Ramanathan and Giuseppe Luigi Banna and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Glen J. Weiss

202 papers receiving 7.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma

2009 833 citations Daniel D. Von Hoff, Patricia LoRusso et al. profile →

Peers

Countries citing papers authored by Glen J. Weiss

Since Specialization

Citations

This map shows the geographic impact of Glen J. Weiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glen J. Weiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glen J. Weiss more than expected).

Fields of papers citing papers by Glen J. Weiss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glen J. Weiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glen J. Weiss. The network helps show where Glen J. Weiss may publish in the future.

Co-authorship network of co-authors of Glen J. Weiss

This figure shows the co-authorship network connecting the top 25 collaborators of Glen J. Weiss. A scholar is included among the top collaborators of Glen J. Weiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glen J. Weiss. Glen J. Weiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk stratification in neuroblastoma patients through machine learning in the multicenter PRIMAGE cohort 2025 ·Frontiers in Oncology ·(unknown), Ana Jiménez-Pastor, (unknown), Glen J. Weiss, L. Cerdá Alberich, (unknown), (unknown), Adela Cañete-Nieto, Sabine Taschner‐Mandl, Barbara Hero, Thorsten Simon, (unknown), Luis Martí‐Bonmatí, Ángel Alberich‐Bayarri	1
2	Overall survival prediction and risk stratification in patients with neuroblastoma through machine learning in the large multi-institutional PRIMAGE cohort. 2024 ·Journal of Clinical Oncology ·(unknown), Ana Jiménez-Pastor, Glen J. Weiss, Leonor Cerdá-Alberich, (unknown), (unknown), Barbara Hero, Ruth Ladenstein, Luis Martí‐Bonmatí, Ángel Alberich‐Bayarri	0
3	Prediction of oncogene mutation status in non-small cell lung cancer: A systematic review and meta-analysis with a special focus on artificial-intelligence-based methods 2024 ·medRxiv ·(unknown), (unknown), (unknown), Ana Jiménez-Pastor, Glen J. Weiss, Luis Martí‐Bonmatí, (unknown), Giuseppe Luigi Banna, Alfredo Addeo, Ángel Alberich‐Bayarri	0
4	Candida expansion in the gut of lung cancer patients associates with an ecological signature that supports growth under dysbiotic conditions 2023 ·Nature Communications ·Bastian Seelbinder, Zoltán Lohinai, Ruben Vazquez-Uribe, Sascha Brunke, (unknown), (unknown), (unknown), Balázs Döme, Zsolt Megyesfalvi, Judit Berta, Gabriella Gálffy, (unknown), Anja Wellejus, Glen J. Weiss, Michael Bauer, Bernhard Hube, Morten Otto Alexander Sommer, Gianni Panagiotou	26
5	Computed Tomography-Based Quantitative Texture Analysis and Gut Microbial Community Signatures Predict Survival in Non-Small Cell Lung Cancer 2023 ·Cancers ·Dávid Dóra, Glen J. Weiss, Zsolt Megyesfalvi, (unknown), (unknown), Anna Kerpel-Fronius, Judit Berta, Judit Moldvay, Balázs Döme, Zoltán Lohinai	8
6	TMB or not TMB as a biomarker: That is the question 2021 ·Critical Reviews in Oncology/Hematology ·Alfredo Addeo, Alex Friedlaender, Giuseppe Luigi Banna, Glen J. Weiss	154
7	Metabolic modeling predicts specific gut bacteria as key determinants for Candida albicans colonization levels 2020 ·The ISME Journal ·(unknown), Sascha Schäuble, Tilman E. Klassert, Sascha Brunke, Philipp Brandt, (unknown), Ruben Vazquez-Uribe, Felipe Senne De Oliveira Lino, Yueqiong Ni, Slavena Vylkova, Hortense Slevogt, Bernhard Hube, Glen J. Weiss, Morten Otto Alexander Sommer, Gianni Panagiotou	32
8	Predictable modulation of cancer treatment outcomes by the gut microbiota 2020 ·Microbiome ·Yoshitaro Heshiki, Ruben Vazquez-Uribe, Jin Li, Yueqiong Ni, (unknown), Lejla Imamovic, Jun Li, (unknown), Bkc Chow, Glen J. Weiss, Aimin Xu, Morten Otto Alexander Sommer, Gianni Panagiotou	121
9	Tumor Cell–Free DNA Copy Number Instability Predicts Therapeutic Response to Immunotherapy 2017 ·Clinical Cancer Research ·Glen J. Weiss, Julia Beck, Donald P. Braun, (unknown), (unknown), (unknown), Walter Quan, Ashish Sangal, Vivek Khemka, (unknown), William M. Mitchell, Howard B. Urnovitz, Ekkehard Schütz	113
10	A prospective pilot study of genome-wide exome and transcriptome profiling in patients with small cell lung cancer progressing after first-line therapy 2017 ·PLoS ONE ·Glen J. Weiss, Sara A. Byron, Jessica Aldrich, Ashish Sangal, (unknown), Jeffrey Kiefer, John D. Carpten, David W. Craig, Timothy G. Whitsett	8
11	A retrospective matched cohort study evaluating the effects of percutaneous endoscopic gastrostomy feeding tubes on nutritional status and survival in patients with advanced gastroesophageal malignancies undergoing systemic anti-cancer therapy 2017 ·PLoS ONE ·Scott C. Mitchell, John P. Williams, (unknown), (unknown), Jeffrey S. Weber, Glen J. Weiss	4
12	Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors 2016 ·Clinical Cancer Research ·Daniel D. Von Hoff, Monica Mita, Ramesh K. Ramanathan, Glen J. Weiss, Alain C. Mita, Patricia LoRusso, Howard A. Burris, Lowell L. Hart, Susan C. Low, Donald M. Parsons, Stephen E. Zale, Jason M. Summa, Hagop Youssoufian, Jasgit C. Sachdev	215
13	Phase I Study of the Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients with Advanced Solid Tumors 2015 ·Clinical Cancer Research ·John Sarantopoulos, Geoffrey I. Shapiro, Roger B. Cohen, Jeffrey W. Clark, John Kauh, Glen J. Weiss, James M. Cleary, Devalingam Mahalingam, Michael D. Pickard, Hélène M. Faessel, Allison Berger, Kristine Burke, George Mulligan, Bruce J. Dezube, R. Donald Harvey	139
14	Safety, Pharmacokinetics, and Pharmacodynamics of a Humanized Anti-Semaphorin 4D Antibody, in a First-In-Human Study of Patients with Advanced Solid Tumors 2015 ·Clinical Cancer Research ·Amita Patnaik, Glen J. Weiss, John E. Leonard, Drew Rasco, Jasgit C. Sachdev, Terrence L. Fisher, Laurie A. Winter, Christine Reilly, Robert B. Parker, (unknown), Lisa Blaydorn, Anthony W. Tolcher, Maurice Zauderer, Ramesh K. Ramanathan	50
15	Mcl-1 Mediates TWEAK/Fn14-Induced Non–Small Cell Lung Cancer Survival and Therapeutic Response 2014 ·Molecular Cancer Research ·Timothy G. Whitsett, Ian T. Mathews, Michael H. Cardone, (unknown), William E. Pierceall, Michael Bittner, Chao Sima, Janine LoBello, Glen J. Weiss, Nhan L. Tran	31
16	Multicenter Phase I Trial of the Mitogen-Activated Protein Kinase 1/2 Inhibitor BAY 86-9766 in Patients with Advanced Cancer 2013 ·Clinical Cancer Research ·Colin D. Weekes, Daniel D. Von Hoff, Alex A. Adjei, (unknown), Sabine Eckhardt, Lia Gore, Karl D. Lewis, Glen J. Weiss, Ramesh K. Ramanathan, Grace K. Dy, Wen Wang, (unknown), Cory Iverson, Jeffrey N. Miner, Zancong Shen, Li‐Tain Yeh, Ronald L. Dubowy, Michael Jeffers, Prabhu Rajagopalan, Neil J. Clendeninn	46
17	Elevated Expression of Fn14 in Non-Small Cell Lung Cancer Correlates with Activated EGFR and Promotes Tumor Cell Migration and Invasion 2012 ·American Journal Of Pathology ·Timothy G. Whitsett, Emily H. Cheng, Landon J. Inge, Kaushal Asrani, Nathan M. Jameson, Galen Hostetter, Glen J. Weiss, Christopher Kingsley, Joseph C. Loftus, Ross M. Bremner, Nhan L. Tran, Jeffrey A. Winkles	45
18	Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Refractory, Locally Advanced or Metastatic Solid Tumors 2011 ·Clinical Cancer Research ·Patricia LoRusso, Charles M. Rudin, Josina C. Reddy, Raoul Tibes, Glen J. Weiss, Mitesh J. Borad, Christine L. Hann, Julie R. Brahmer, Ilsung Chang, Walter C. Darbonne, Richard Graham, Kenn L. Zerivitz, Jennifer A. Low, Daniel D. Von Hoff	420
19	Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of TH-302, a Hypoxia-Activated Prodrug, in Patients with Advanced Solid Malignancies 2011 ·Clinical Cancer Research ·Glen J. Weiss, Jeffrey R. Infante, E. Gabriela Chiorean, Mitesh J. Borad, Johanna C. Bendell, Julian R. Molina, Raoul Tibes, Ramesh K. Ramanathan, (unknown), Suzanne F. Jones, Mario E. Lacouture, Virginia K. Langmuir, (unknown), Stew Kroll, Howard A. Burris	122
20	Basal cell carcinoma (BCC) causing spinal cord compression. 2000 ·PubMed ·Bruce H. Cohen, Glen J. Weiss, Hongwei Yin	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact